Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 77.53%
March 31, 2026 77.45%
December 31, 2025 77.62%
September 30, 2025 74.19%
June 30, 2025 71.69%
March 31, 2025 72.51%
December 31, 2024 74.02%
September 30, 2024 73.70%
June 30, 2024 73.65%
March 31, 2024 74.14%
December 31, 2023 74.18%
September 30, 2023 73.74%
June 30, 2023 74.06%
March 31, 2023 72.85%
December 31, 2022 72.51%
Date Value
September 30, 2022 74.45%
June 30, 2022 74.68%
March 31, 2022 75.21%
December 31, 2021 74.78%
September 30, 2021 73.44%
June 30, 2021 73.99%
March 31, 2021 71.52%
December 31, 2020 72.00%
September 30, 2020 70.32%
June 30, 2020 27.55%
March 31, 2020 65.56%
December 31, 2019 70.91%
September 30, 2019 70.38%
June 30, 2019 67.24%
March 31, 2019 64.33%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 57.05%
AngioDynamics, Inc. 56.00%
Alphatec Holdings, Inc. 62.90%
AtriCure, Inc. 76.75%
Baxter International, Inc. 33.55%

Gross Profit Margin (Quarterly) Related Metrics